Monday, October 25, 2021
85.9 F
Fort Worth

Mylan launches cheaper version of EpiPen allergy treatment

🕐 1 min read

Drugmaker Mylan has started selling a generic version of its emergency allergy treatment EpiPen at half the price of the branded option, the cost of which drew national scorn and attracted Congressional inquiries.

The launch of Mylan’s long-promised generic alternative is expected to still generate millions of dollars in revenue for the drugmaker while also protecting its market share against current and future competition.

Mylan NV said Friday that it will charge $300 for the generic version of its life-saving injections, which come in a two pack. The generic version will reach retail pharmacies starting next week.

The list price of an EpiPen two-pack, which is stocked by schools and parents of children with severe allergies, has grown to $608, an increase of more than 500 percent since 2007.

Earlier this year, a Congressional panel grilled Mylan CEO Healthier Bresch about the soaring cost, which she has blamed in part on an outdated and complex system for pricing drugs.

Shares of the drugmaker climbed 1.5 percent, or 57 cents, to $38.33 in pre-market trading before markets opened Friday.

Related Articles

Our Digital Sponsors

Latest Articles

Texas Rangers
Fort Worth Business Press Logo
This advertisement will close in
00
Months
00
Days
00
Hours
00
Minutes
00
Seconds
seconds..
Click here to continue to Fort Worth Business Press

Not ready to subscribe?

Try a few articles on us.

Enter your email address and we will give you access to three articles a month, to give us a try. You also get an opportunity to receive our newsletter with stories of the day.

This field is for validation purposes and should be left unchanged.

Get our email updates

Stay up-to-date with the issues, companies and people that matter most to business in the Fort Worth.

  • Restaurants
  • Technology
  • and more!

FWBP Morning Brief

FWBP 5@5

Weekend Newsletter

  • Banking & Finance
  • Culture
  • Real Estate